SeaStar Medical Holding Corp (ICU) (Q3 2026) Earnings Call Highlights: Qualimmune Revenue Jumps ...
SeaStar Medical Holding Corp (ICU) posted strong Qualimmune revenue growth and new FDA breakthrough designation, though pivotal trial enrollment was extended to mid-2027 amid widening net losses. Related Stocks: ICU ,